Coagulation disorders during treatment with cefazolin and rifampicin: rare but dangerous

We describe a 79-year-old man with spondylodiscitis and unknown pathogen, treated with cefazolin and rifampicin. He developed a massive digestive hemorrhage. Prothrombin time was prolonged with severe vitamin-K-dependent clotting-factor deficiency. Severe bleeding can occur during cefazolin and rifa...

Descripción completa

Detalles Bibliográficos
Autores principales: Kouki, Ines, Montagner, Clémence, Mauhin, Wladimir, London, Jonathan, Lazard, Thierry, Grimbert, Sylvie, Zeller, Valérie, Lidove, Olivier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Copernicus GmbH 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8131959/
https://www.ncbi.nlm.nih.gov/pubmed/34084701
http://dx.doi.org/10.5194/jbji-6-131-2021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8131959/
https://www.ncbi.nlm.nih.gov/pubmed/34084701
http://dx.doi.org/10.5194/jbji-6-131-2021

Ejemplares similares